Autres langues Bally's Corporation

Actions

BALY

US05875B1061

Marché Fermé - Nyse Autres places de cotation 22:00:02 26/04/2024			Varia. 5j.	Varia. 1 janv.
13,96 ^USD	-0,29 %		-3,72 %	+0,14 %

23/04	BALLY'S CORPORATION : Truist Securities réitère son opinion positive sur le titre	ZM
15/04	Trinity Health dépose un avis de sollicitation exemptée auprès de Bally?s Corporation	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bally’s to Report First Quarter 2024 Results on May 1, 2024	18/04
Bally’s Atlantic City Celebrates 45th Anniversary	17/04
Trinity Health Files a Notice of Exempt Solicitation to Bally?s Corporation	15/04
Sector Update: Consumer Stocks Mixed Pre-Bell Monday	15/04
Sector Update: Consumer	15/04
Bally's Files Prospectus for Secondary Offering of 7.9 Million Shares	15/04
Trinity Health Submits a Shareholder Proposal to Bally's Corporation	05/04
K&F Growth Capital Issues Letter to the Board of Directors of Bally?s Corporation	02/04
Special Committee of Bally’s Retains Financial and Legal Advisors in Connection With Standard General’s Proposal	28/03
Bally's Establishes Special Committee to Evaluate Standard General Buyout Proposal	12/03
Bally’s Forms Special Committee to Evaluate Preliminary, Non-Binding Acquisition Proposal by Standard General	12/03
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading	11/03
Sector Update: Consumer Stocks Mixed in Afternoon Trading	11/03
Sector Update: Consumer	11/03
Top Stories at Midday: Bally's Gets Takeover Proposal; Eli Lilly's Eczema Study Results; Reddit's Expected IPO Price Range; FDA Backs Mesoblast Heart Therapy's Approval Pathway	11/03
Bally's Shareholder Standard General Delivers Takeover Bid	11/03
Bally's Receives Acquisition Offer From Standard General at $15 Per Share	11/03
Earnings Flash (BALY) BALLY'S CORPORATION Reports Q4 Revenue $611.7M, vs. Street Est of $623.1M	21/02
Bally’s Corporation Announces Fourth Quarter and Full Year 2023 Results	21/02
Bally's Corporation Reports Impairment for the Fourth Quarter of 2023	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bally's Corporation

Actions

BALY

US05875B1061

Autres langues

Filtres